文献速递关节外科创伤骨科

低剂量阿司匹林在翻修全髋关节置换术后预防静脉血栓栓塞安全有效:一项回顾性队列研究

Low-Dose Aspirin Is Safe and Effective for Venous Thromboembolism Prevention in Patients Undergoing Revision Total Hip Arthroplasty: A Retrospective Cohort Study.
PubMed 文献 · J Arthroplasty · 2020-03-30

本研究回顾性分析2011-2019年1361例翻修全髋关节置换术患者,比较81mg与325mg阿司匹林每日两次预防静脉血栓栓塞的效果与安全性。结果显示两种剂量在术后肺栓塞、深静脉血栓、出血并发症、感染率及死亡率上均无显著差异,81mg阿司匹林非劣于325mg。

要点

  • 81mg阿司匹林每日两次与325mg在翻修全髋术后预防VTE效果无显著差异。
  • 两种剂量在出血并发症、感染率及死亡率方面均无显著差异。
  • 81mg阿司匹林每日两次可作为翻修全髋术后VTE预防的安全有效选择。

核心结论

  • 81mg阿司匹林每日两次在翻修全髋关节置换术后预防VTE方面非劣于325mg每日两次,可能安全有效。

研究设计与样本

  • 回顾性队列研究,纳入2011-2019年单中心1361例连续翻修全髋关节置换术患者,比较81mg与325mg阿司匹林每日两次的90天术后并发症。

主要发现

  • 2011-2017年973例翻修全髋中诊断13例VTE(1.34%),2017-2019年388例中诊断3例VTE(0.77%)。

关键数值与推荐

  • 81mg阿司匹林每日两次与325mg每日两次在翻修全髋术后90天内VTE发生率无显著差异。
  • 出血并发症、急性假体周围感染及死亡率在两种剂量间无显著差异。

临床怎么用

  • 对于标准风险的翻修全髋关节置换术患者,可考虑使用81mg阿司匹林每日两次预防VTE。
  • 低剂量阿司匹林方案在保持低VTE发生率的同时未增加出血、感染或死亡风险。

局限性

  • 回顾性研究设计可能存在选择偏倚和未测量混杂因素。
  • 单中心研究,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Currently, there is no established universal standard of care for prophylaxis against venous thromboembolism (VTE) in orthopedic patients undergoing revision total hip arthroplasty (rTHA). The aim of this study is to determine whether a protocol of 81-mg aspirin (ASA) bis in die (BID) is safe and/or effective in preventing VTE in patients undergoing rTHAs vs 325-mg ASA BID. METHODS: In 2017, a large academic medical center adopted a new protocol for VTE prophylaxis in arthroplasty patients at standard risk. Initially, patients received 325-mg ASA BID but switched to 81-mg ASA BID. A retrospective review (2011-2019) was performed to identify 1361 consecutive rTHA patients and their associated 90-day postoperative complications such as VTE, including pulmonary embolism (PE) and/or deep vein thrombosis (DVT), as the primary outcome; and gastrointestinal and wound bleeding, acute periprosthetic joint infection, and mortality as the secondary outcome. RESULTS: From 2011 to 2017, 973 rTHAs were performed and 13 total VTE cases were diagnosed (1.34%). From 2017 to 2019, 388 rTHAs were performed with 3 total VTE cases identified (0.77%). Chi-squared analyses and logistic regression models showed no differences in rates or odds in postoperative PE (P = .09), DVT (P = .79), PE and DVT (P = .85), and total VTE (P = .38) using either dose. There were also no differences between bleeding complications (P = .14), infection rate (P = .46), and mortality (P = .53). CONCLUSION: Using a protocol of 81-mg of ASA BID is noninferior to 325-mg ASA BID and may be safe and effective in maintaining low rates of VTE in patients undergoing rTHA.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Tang A, Zak S, Iorio R, et al. Low-Dose Aspirin Is Safe and Effective for Venous Thromboembolism Prevention in Patients Undergoing Revision Total Hip Arthroplasty: A Retrospective Cohort Study. J Arthroplasty. 2020. PMID: 32334898. doi:10.1016/j.arth.2020.03.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。